Celator Pharmaceuticals Inc — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/790c3059-25b1-4a75-87de-ecb61827b2de/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-19.3M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-089052 |
| FY 2014 | $-16.9M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016717 |
| FY 2013 | $-136.7M | 1999-11-01 – 2014-03-31 | evidence 0001144204-14-029539 |
| FY 2012 | $-121.3M | 1999-11-19 – 2013-03-31 | evidence 0001193125-13-344958 |
| FY 2011 | $-14.2M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-222290 |
| FY 2010 | $-10.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-222290 |
| FY 2009 | $-10.0M | 2009-01-01 – 2009-12-31 | evidence 0001193125-13-222290 |
| FY 2008 | $-14.0M | 2008-01-01 – 2008-12-31 | evidence 0001193125-13-222290 |
| FY 2007 | $-16.8M | 2007-01-01 – 2007-12-31 | evidence 0001193125-13-222290 |
| FY 2006 | $-14.6M | 2006-01-01 – 2006-12-31 | evidence 0001193125-13-222290 |
| FY 2005 | $-8.9M | 2005-01-01 – 2005-12-31 | evidence 0001193125-13-222290 |
| FY 2004 | $-5.4M | 2004-01-01 – 2004-12-31 | evidence 0001193125-13-222290 |
| FY 2003 | $-3.5M | 2003-01-01 – 2003-12-31 | evidence 0001193125-13-222290 |
| FY 2002 | $-1.5M | 2002-01-01 – 2002-12-31 | evidence 0001193125-13-222290 |
| FY 2001 | $-773.7k | 2001-01-01 – 2001-12-31 | evidence 0001193125-13-222290 |
| FY 2000 | $-200.1k | 2000-01-01 – 2000-12-31 | evidence 0001144204-14-017335 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).